MedPath

Incidence Of Hemidiaphragmatic Paralysis After Usg Guided Low Dose Interscalene Brachial Plexus Block

Not Applicable
Completed
Conditions
Respiratory Insufficiency
Interventions
Drug: IV diclofenac and IV paracetamol
Device: Interscalene Block with Ropivacaine Hcl 0.2% Inj Vil 10Ml
Registration Number
NCT03081728
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Brief Summary

to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug followed by 24 hours continous infusion of drug

Detailed Description

to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug followed by 24 hours continous infusion of drug. To see hemidiaphragmatic paralysis by seeing diaphragmatic excursion on M mode Usg subcostal approach, to see post operative pain, patient satisfaction score, complications if any

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Patients aged 18-65 years and belonging to ASA grade I, II, III, undergoing either, shoulder surgery, (rotator cuff repair, acromioplasty, hemiarthroplasty, and total shoulder replacement) or surgery for proximal humerus fracture will be recruited for the study.
Exclusion Criteria
  • a) Patient refusal for interscalene block b) Severe respiratory disease (FEV1/FVC <0.7 and FEV1 < 80% of predicted) c) Allergy to amide local anaesthetic drugs d) Chronic opioid therapy e) Patients who cannot understand how to operate PCA and VAS

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
controlIV diclofenac and IV paracetamolIV analgesia only with diclofenac and paracetamol
blockInterscalene Block with Ropivacaine Hcl 0.2% Inj Vil 10Mlwill be given block and continuous infusion with bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine
Primary Outcome Measures
NameTimeMethod
incidence of hemidiaphragmatic paralysis24 hours

incidence of hemidiaphragmatic paralysis by M mode USG to be seen

Secondary Outcome Measures
NameTimeMethod
postoperative pain24 hours

VAS score will taken

Trial Locations

Locations (1)

PGIMER

🇮🇳

Chandigarh, India

© Copyright 2025. All Rights Reserved by MedPath